New approach for improving the safety of oral immunotherapy for food allergy

A. Urisu, K. Tanaka, K. Ogura, N. Naruse, N. Hirata, Y. Nakajima, C. Inuo, S. Suzuki, H. Ando, Y. Kondo, I. Tsuge, K. Yamada, M. Kimura

研究成果: Review article

2 引用 (Scopus)

抄録

Avoidance of causative foods is the mainstay of therapy for food allergy. This therapy places a burden, to a greater or lesser extent, on food-allergic patients and their parents if they are children. They always face the probable risk of an unexpected accident resulting from intake of a causative food. Allergen-specific immunotherapy for pollinosis and bee-venom allergy has been proven efficient and common in clinical practice. Recently, reports on oral immunotherapy (OIT) for food allergy have been increasing, and OIT has drawn attention as a therapy with the possibility of providing a cure for food allergy. Initially, we review the present status of oral antigen-specific immunotherapy for food allergy. Overall, OIT for food allergy is promising with regard to an increase in tolerance to causative foods. However, several concerns regarding safety remain. Subsequently, we review new approaches for improving the safety of OIT, including sublingual immunotherapy and modified antigens for OIT. We briefly summarize our study on OIT using heated and ovomucoid-reduced egg white as an example of a hypoallergenic antigen for safer OIT.

元の言語English
ページ(範囲)25-28
ページ数4
ジャーナルClinical and Experimental Allergy Reviews
12
発行部数SUPPL.N2
DOI
出版物ステータスPublished - 01-11-2012

Fingerprint

Food Hypersensitivity
Immunotherapy
Safety
Food
Antigens
Ovomucin
Sublingual Immunotherapy
Bee Venoms
Immunologic Desensitization
Egg White
Seasonal Allergic Rhinitis
Accidents
Hypersensitivity
Therapeutics
Parents

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

これを引用

Urisu, A. ; Tanaka, K. ; Ogura, K. ; Naruse, N. ; Hirata, N. ; Nakajima, Y. ; Inuo, C. ; Suzuki, S. ; Ando, H. ; Kondo, Y. ; Tsuge, I. ; Yamada, K. ; Kimura, M. / New approach for improving the safety of oral immunotherapy for food allergy. :: Clinical and Experimental Allergy Reviews. 2012 ; 巻 12, 番号 SUPPL.N2. pp. 25-28.
@article{50a51818ce0b4941b26a3941fdcf3c72,
title = "New approach for improving the safety of oral immunotherapy for food allergy",
abstract = "Avoidance of causative foods is the mainstay of therapy for food allergy. This therapy places a burden, to a greater or lesser extent, on food-allergic patients and their parents if they are children. They always face the probable risk of an unexpected accident resulting from intake of a causative food. Allergen-specific immunotherapy for pollinosis and bee-venom allergy has been proven efficient and common in clinical practice. Recently, reports on oral immunotherapy (OIT) for food allergy have been increasing, and OIT has drawn attention as a therapy with the possibility of providing a cure for food allergy. Initially, we review the present status of oral antigen-specific immunotherapy for food allergy. Overall, OIT for food allergy is promising with regard to an increase in tolerance to causative foods. However, several concerns regarding safety remain. Subsequently, we review new approaches for improving the safety of OIT, including sublingual immunotherapy and modified antigens for OIT. We briefly summarize our study on OIT using heated and ovomucoid-reduced egg white as an example of a hypoallergenic antigen for safer OIT.",
author = "A. Urisu and K. Tanaka and K. Ogura and N. Naruse and N. Hirata and Y. Nakajima and C. Inuo and S. Suzuki and H. Ando and Y. Kondo and I. Tsuge and K. Yamada and M. Kimura",
year = "2012",
month = "11",
day = "1",
doi = "10.1111/j.1472-9733.2012.01167.x",
language = "English",
volume = "12",
pages = "25--28",
journal = "Clinical and Experimental Allergy Reviews",
issn = "1472-9725",
publisher = "Wiley-Blackwell",
number = "SUPPL.N2",

}

Urisu, A, Tanaka, K, Ogura, K, Naruse, N, Hirata, N, Nakajima, Y, Inuo, C, Suzuki, S, Ando, H, Kondo, Y, Tsuge, I, Yamada, K & Kimura, M 2012, 'New approach for improving the safety of oral immunotherapy for food allergy', Clinical and Experimental Allergy Reviews, 巻. 12, 番号 SUPPL.N2, pp. 25-28. https://doi.org/10.1111/j.1472-9733.2012.01167.x

New approach for improving the safety of oral immunotherapy for food allergy. / Urisu, A.; Tanaka, K.; Ogura, K.; Naruse, N.; Hirata, N.; Nakajima, Y.; Inuo, C.; Suzuki, S.; Ando, H.; Kondo, Y.; Tsuge, I.; Yamada, K.; Kimura, M.

:: Clinical and Experimental Allergy Reviews, 巻 12, 番号 SUPPL.N2, 01.11.2012, p. 25-28.

研究成果: Review article

TY - JOUR

T1 - New approach for improving the safety of oral immunotherapy for food allergy

AU - Urisu, A.

AU - Tanaka, K.

AU - Ogura, K.

AU - Naruse, N.

AU - Hirata, N.

AU - Nakajima, Y.

AU - Inuo, C.

AU - Suzuki, S.

AU - Ando, H.

AU - Kondo, Y.

AU - Tsuge, I.

AU - Yamada, K.

AU - Kimura, M.

PY - 2012/11/1

Y1 - 2012/11/1

N2 - Avoidance of causative foods is the mainstay of therapy for food allergy. This therapy places a burden, to a greater or lesser extent, on food-allergic patients and their parents if they are children. They always face the probable risk of an unexpected accident resulting from intake of a causative food. Allergen-specific immunotherapy for pollinosis and bee-venom allergy has been proven efficient and common in clinical practice. Recently, reports on oral immunotherapy (OIT) for food allergy have been increasing, and OIT has drawn attention as a therapy with the possibility of providing a cure for food allergy. Initially, we review the present status of oral antigen-specific immunotherapy for food allergy. Overall, OIT for food allergy is promising with regard to an increase in tolerance to causative foods. However, several concerns regarding safety remain. Subsequently, we review new approaches for improving the safety of OIT, including sublingual immunotherapy and modified antigens for OIT. We briefly summarize our study on OIT using heated and ovomucoid-reduced egg white as an example of a hypoallergenic antigen for safer OIT.

AB - Avoidance of causative foods is the mainstay of therapy for food allergy. This therapy places a burden, to a greater or lesser extent, on food-allergic patients and their parents if they are children. They always face the probable risk of an unexpected accident resulting from intake of a causative food. Allergen-specific immunotherapy for pollinosis and bee-venom allergy has been proven efficient and common in clinical practice. Recently, reports on oral immunotherapy (OIT) for food allergy have been increasing, and OIT has drawn attention as a therapy with the possibility of providing a cure for food allergy. Initially, we review the present status of oral antigen-specific immunotherapy for food allergy. Overall, OIT for food allergy is promising with regard to an increase in tolerance to causative foods. However, several concerns regarding safety remain. Subsequently, we review new approaches for improving the safety of OIT, including sublingual immunotherapy and modified antigens for OIT. We briefly summarize our study on OIT using heated and ovomucoid-reduced egg white as an example of a hypoallergenic antigen for safer OIT.

UR - http://www.scopus.com/inward/record.url?scp=84867393739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867393739&partnerID=8YFLogxK

U2 - 10.1111/j.1472-9733.2012.01167.x

DO - 10.1111/j.1472-9733.2012.01167.x

M3 - Review article

AN - SCOPUS:84867393739

VL - 12

SP - 25

EP - 28

JO - Clinical and Experimental Allergy Reviews

JF - Clinical and Experimental Allergy Reviews

SN - 1472-9725

IS - SUPPL.N2

ER -